GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
The Defense Production Act allows federal agencies to require companies to prioritize government contracts for medical supplies to address national emergencies, like COVID-19. Federal agencies have used DPA authorities to expand production of COVID-related medical supplies.
The Office of National Drug Control Policy (ONDCP) coordinates the nation's drug control policy. ONDCP's responsibilities include tracking and publicizing information about federal grants that fund drug control activities, such as prevention and treatment.
As the nation continues to respond to and recover from the COVID-19 pandemic, recent increases in cases have hampered these efforts and created new challenges.
In our 8th comprehensive report, we found more ways to help the federal government address the pandemic and prepare for future emergencies.
We surveyed people whose email addresses were attached to public comments on proposed rules from 10 federal agencies. From 5% to 30% of the people (depending on the agency) said they did not make the comment. At 8 agencies, most of the comments did not have email addresses.